pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-124-1 |
Genomic Coordinates | chr8: 9903388 - 9903472 |
Description | Homo sapiens miR-124-1 stem-loop |
Comment | miR-124 was first identified by cloning studies in mouse . The 5' end of the miRNA may be offset with respect to previous annotations. |
RNA Secondary Structure | |
Associated Diseases | |
pre-miRNA | hsa-mir-124-2 |
Genomic Coordinates | chr8: 64379149 - 64379257 |
Description | Homo sapiens miR-124-2 stem-loop |
Comment | miR-124 was first identified by cloning studies in mouse . The 5' end of the miRNA may be offset with respect to previous annotations. |
RNA Secondary Structure | |
Associated Diseases | |
pre-miRNA | hsa-mir-124-3 |
Genomic Coordinates | chr20: 63178500 - 63178586 |
Description | Homo sapiens miR-124-3 stem-loop |
Comment | miR-124 was first identified by cloning studies in mouse . The 5' end of the miRNA may be offset with respect to previous annotations. |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-124-5p | ||||||||||||||||||||||||||||||
Sequence | 14| CGUGUUCACAGCGGACCUUGAU |35 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | Cloned | ||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SDC3 | ||||||||||||||||||||
Synonyms | SDCN, SYND3 | ||||||||||||||||||||
Description | syndecan 3 | ||||||||||||||||||||
Transcript | NM_014654 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SDC3 | |||||||||||||||||||||
3'UTR of SDC3 (miRNA target sites are highlighted) |
>SDC3|NM_014654|3'UTR 1 TGGAGCCACAGTGCCTCCCTGCAGCCTCAACACCACCCTGCTGTCCAGTCCCCAGCCTGGCCCCACCAGCCCAAGCCTGG 81 GACTGGGCCTGGAACCTGGCCCCAGTTCTTCTCTGCCCTCTCTCCCAAGGTCTGCCCAGGCTGCCAGCCTCACACAGATC 161 TTCCCCGAGGAAGAGGGGCTGCTGCCATCTGCCCCAGACTGTGCCCTTACGAGCTCATCTCTTGTTCCCCTCATCCCTGC 241 CACCAGTCTGGGGCTTCAGGACCTCATGTCAGATGGATGGGAGGAAGAAAGCTCCTGATTGGCTGGTGGTGGAAGAAAGG 321 GTGGGGCTTGAGATGAGCCTGAGCCCTGACTTGGCACCCACAGTGCTCACTGAGATCTCCTTTTTGGGGCAGAGAGGCAC 401 TCAGGCTGGTTTCCAGGACAAACATTTGGTAAACACAGCCCTTGAAATCATCTAGACACTGCAACCTCTTGCTCGTATCC 481 CAGGGCCTCTCTCTAGCTGGGTGAGAGGGTGTCCCTTGTCACCAGCCTGTTTTGTCCTGGTCTCTCTGGGGTTGTTGAAT 561 CTCTCCTCTTGCCTGCCAAGTACACATGTACCCAGACTTCATTTCTTTCTGCATCTTCCCCCAAGAAACAGCTTCCTGAG 641 GGTGCTGGGGCAGCCACTGGTGAGGAGGGGCTGCTCTGATGTCCCTCCTATGAGGGGACTCTGCACAGACACCATTGCCC 721 ACACTATCACCATATTTTCACTCAGTCACACACAAGACAAAAGCATGCAATGACAAAACCATACGCAATCCTGACCGCCC 801 AGCCAATCAAGACATATCACAGAACACACGCGTCCTTCCAAGAATGTTTATCCTCATGCATCACTTACACACCCCCAGAC 881 ACGTACTGCAATGCAAGTCACTAGTCATGGTCACATGACAGTGACAGTGTGGCCTCCTCCTACCCCAAATACACCCACAC 961 TCTGGCACCACACACATTGTCTCCAGCTTTCAGGCTTACTGGGGAGGGTGGAATCGAGCCAGAACAATCAGCCCATATTG 1041 GGTCCCCCTAAGTTGCCCCGTCATACTCAGTCCCATGCCATGGTGCCCACACCAACCATGCAGCCGCCAACCCCAGCCAG 1121 TGTCAGACACAATCCCATGTGGATGCACAGTCTCACTCCACATGACCTGCTCTCAATGCTGGAGGGAAACAGGCAGGCCC 1201 TTGCCTTTCTCGGAAAAAGTGTGGGGCCACAGCCCTTTTAGGGCATTGCATGCAGGTGGGCCTGGCTTCACCCCTACCTG 1281 CTTCCTCCCCACCGCAGCTGGCAGAGGGGGAGGTTTGGGGCCAGACCCCCACTAGCTGGGAGCCTGGGGGCTCCTCTAAG 1361 GCTGAGGAAGGAAATTTGGCCCCAGGTTGTTGGGGGGTCTTGGGTCTCCCAGGACGGAAGGCCCAGGGCAGGGAGGGGGC 1441 ATGTGGTTGGGCTCCTTTATCTCCCTGTGTCCCCTTCCTGCTTTGAGCTAGGGGGCTGACTCTGCCTCCCAGGACACAAG 1521 TCTCCAAAGTGCCTGTGAGGGCGGGCCCTCCGCACCCTCTGCCCTCTGCCTGGCAGGCCAACCTCAGCCCACCTGCCCAG 1601 AGGCCCTCCCTGTGGACACCCCCTCACCTATTTGGCCAAACAATTCTGGCTGCAGCTTCAGGGGCCATGGCTGGAAGCAG 1681 CCCCTGCAGATCCCTCAGGCCCCGAGGTCAGGGTTTGAGGGATGAGACCAGGTGATAGTGGGGGAGGGGTTACTTCCTTT 1761 GTTACCTAGCAAGTAGGGCTATTTCCATCGGTATTTTAAATGTGGGGTCACAGATCTTTTGGGGAGGGTGTGCTTGGCAG 1841 GGGGCCTCTTGGAGCCAAAGGGATGTGGTGTGAGTTGCGATTGGCTGGCACTCACACCCCCACCCCTCACCCACATCCCA 1921 GATTCAAGTCAGGAAGGCAGGTTTTATTTCAGGGCCCTTTTCAAGATGCCCTGGCAGCAGATTTCTGCAGGATGAGGGGT 2001 AGCGGTGTGTAGGCAGTGAGGGGGAGGTTCCAGGGGCTGTCCCACAGCCTGTCTTTTCCAGGCTGGGCTCCATCTTCCAG 2081 TCCCAAAACCCTCCTTCACAGGGCCCAGAGGCTTGTGAGGAAGCCAGGTGGACCCAGCCTTAGAAGAGTGGGCATGGGGG 2161 GCCCCTGATATCTGGAGGGGGCGGGTTGGCCTCAGTCATCTTTGGAGCAGAAGGGCTGGGTCCTGGGGCCACAGACCACA 2241 AGGCTCAGCCTCCCTACCCTGCTCCCTGGGGTGCTGCTGTCTTGGAGAGCACAGCTCTGGTGAGACGGCCTGGGCAGGCC 2321 GAGGCTGAGAAACCAGGGAGGATAGAGGAGAAAAGGGCTTGGGCCCCCAGCCCCAGAAGATGCTGGACCCCAGGTGGGAG 2401 ACCCAACAGTGGGTGCAGTTTCTCAGTAGGGCTGGAGCCAATGGTGGGGGTGGCCCCGGCAGGCCTGGCTCCTCACATCC 2481 CAGGGGTTGGCTTCTGATTTGGGGCTTGGGCTCCAGGCACTGGCTTCTCTTCTCTGTGTCCTTAGCATTTGAGAGAAGAG 2561 GCCAGGGGCCTTGTTCATGGATCCCTGGACCCAAGGCAGATGTCCAGGCTTTATCCTCCTGAGGATGAGGAGTCTGACCA 2641 GCCCAAATCTGCCCTGGCCGGCCTGACCGGGGCAAGGCAGTCCAAGAGAGTTCAGTGAGGACCAGCTAGGCTCTCCCAGG 2721 TGCAATGTGGGTGCAGGGCCCTCATGTCCCCCTACCCCTGCCTGTGATGGAGTGTTCTGAGGGGCTTTGGCATTTGCTGG 2801 AAGCACAGGGAGTTCCAAATGAGAGGGAGCTTCTGTGGCTTGAGAGCCTCTGGGGCCTTGGCTGCCAGAGCACGAGGCAG 2881 GCCAGGACCTGGAGAGCCCAGACCCTGTCTCCAGGAGGCCAGGAGGCCAGATGGGGGCCTTGCCTGAAAGACTGGTCCCC 2961 TTGATCGCTGGAGGCATGTGGGTGGCAACCAGGGCTGGGCAGGGCTTAGGGTGTGTGGGCCAAACCCCCCTGGGGTTGGC 3041 AAAGCCGCCTGTCAGGCCTCCTGGTGGGGGCCCCTGGACACAGGGAGCAGACCCTCTGCCTCATGGGGTAGGAGTGGCTG 3121 CCTCCTGTGTTCTCTGGATTTCTTCTCCCAACAACTACAACCCTGGACTTGCCTCCCCAGGCCTCTTGCCTGTAAATAGA 3201 AGCCCGCAAACTGTACAGATTTACAGAGGCATCGAGACTGGGCCCTGGGAGTTGCCATCTGAGAGCCGATGGCCCCAGCA 3281 TCCCCCAGGTGCCTGCCTGGCACCACAGTGACCCTGGCCTCAGCGTGGCAAATGCATGTAAATATTTTTCGTAGGCAGCG 3361 TGGCTCCAGAGAGCCCCCTGAAGACAGTGTCCCTCCCTCCTGTGAGTCCTTTCTCCTGTACAGAACCTGCCTGGGGTGGG 3441 TGGGGGTCTGCCATTCCCTCCCCCAGGCCTTCCCTGCCCCTTCTCTCCCCTGTAACCTGTTTATTAACCATACCTGTCCT 3521 GAGTTCATGGCCAAAACCTTAAATAAGAAAAACAAAAGAAAAAGACAGTGGAAAAAAGAGACCAAGGCGCCTGCCCCACT 3601 GCGGGTACTCTCCTGTTCCAGCCTTGTGAAGGAACTGGTTTTGTTTTTGTTTTTTTTTTTTTTTTTTTTTTTTTGTTTGT 3681 TTGTTTTTTTAACACTTCCTGTGCTGTGCCCATTTATAAGAGGAAATAAAATTAAGCTGAAATGA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | BC-1 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796037. RNA binding protein: AGO2. Condition:4-Thiouridine
PAR-CLIP data was present in GSM796038. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
CLIP-seq Support 1 for dataset GSM796037 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-1 / 4-Thiouridine |
Location of target site | ENST00000336798.7 | 3UTR | UCAAGACAUAUCACAGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM796038 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-1 / 4-Thiouridine |
Location of target site | ENST00000336798.7 | 3UTR | UCAAGACAUAUCACAGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
65 hsa-miR-124-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT064177 | KIAA1804 | mitogen-activated protein kinase kinase kinase 21 | 2 | 2 | ||||||||
MIRT069736 | FOXG1 | forkhead box G1 | 2 | 4 | ||||||||
MIRT086429 | NABP1 | nucleic acid binding protein 1 | 2 | 6 | ||||||||
MIRT105334 | SLC7A2 | solute carrier family 7 member 2 | 2 | 4 | ||||||||
MIRT110455 | PLEKHA1 | pleckstrin homology domain containing A1 | 2 | 2 | ||||||||
MIRT172998 | YTHDF3 | YTH N6-methyladenosine RNA binding protein 3 | 2 | 2 | ||||||||
MIRT196428 | TAOK1 | TAO kinase 1 | 2 | 14 | ||||||||
MIRT325704 | CSTF2 | cleavage stimulation factor subunit 2 | 2 | 2 | ||||||||
MIRT365670 | TSC22D3 | TSC22 domain family member 3 | 2 | 4 | ||||||||
MIRT365873 | XIAP | X-linked inhibitor of apoptosis | 2 | 2 | ||||||||
MIRT404126 | ASB1 | ankyrin repeat and SOCS box containing 1 | 2 | 2 | ||||||||
MIRT404626 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 2 | ||||||||
MIRT405284 | ARF1 | ADP ribosylation factor 1 | 2 | 2 | ||||||||
MIRT406099 | PAGR1 | PAXIP1 associated glutamate rich protein 1 | 2 | 2 | ||||||||
MIRT446627 | SDC3 | syndecan 3 | 2 | 2 | ||||||||
MIRT446906 | RGS5 | regulator of G protein signaling 5 | 2 | 2 | ||||||||
MIRT461790 | FXR2 | FMR1 autosomal homolog 2 | 2 | 2 | ||||||||
MIRT463982 | WEE1 | WEE1 G2 checkpoint kinase | 2 | 4 | ||||||||
MIRT464204 | VGLL4 | vestigial like family member 4 | 2 | 2 | ||||||||
MIRT472790 | MTMR4 | myotubularin related protein 4 | 2 | 4 | ||||||||
MIRT473485 | MCFD2 | multiple coagulation factor deficiency 2 | 2 | 2 | ||||||||
MIRT481124 | AZIN1 | antizyme inhibitor 1 | 2 | 4 | ||||||||
MIRT485060 | SUCO | SUN domain containing ossification factor | 2 | 2 | ||||||||
MIRT487343 | HLA-DRA | major histocompatibility complex, class II, DR alpha | 2 | 2 | ||||||||
MIRT491948 | VPS52 | VPS52, GARP complex subunit | 2 | 2 | ||||||||
MIRT497208 | CDH7 | cadherin 7 | 2 | 2 | ||||||||
MIRT497476 | TOR1AIP2 | torsin 1A interacting protein 2 | 2 | 2 | ||||||||
MIRT528203 | NELFE | negative elongation factor complex member E | 2 | 2 | ||||||||
MIRT529255 | TRIM4 | tripartite motif containing 4 | 2 | 4 | ||||||||
MIRT530096 | PSAPL1 | prosaposin like 1 (gene/pseudogene) | 2 | 2 | ||||||||
MIRT530597 | C7orf33 | chromosome 7 open reading frame 33 | 2 | 4 | ||||||||
MIRT534980 | PSAT1 | phosphoserine aminotransferase 1 | 2 | 4 | ||||||||
MIRT538326 | CSGALNACT1 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | 2 | 2 | ||||||||
MIRT561237 | ZNF652 | zinc finger protein 652 | 2 | 2 | ||||||||
MIRT562035 | KRAS | KRAS proto-oncogene, GTPase | 2 | 2 | ||||||||
MIRT563120 | THAP5 | THAP domain containing 5 | 2 | 2 | ||||||||
MIRT563538 | RBM41 | RNA binding motif protein 41 | 2 | 2 | ||||||||
MIRT566037 | REV3L | REV3 like, DNA directed polymerase zeta catalytic subunit | 2 | 2 | ||||||||
MIRT566505 | PAWR | pro-apoptotic WT1 regulator | 2 | 2 | ||||||||
MIRT566745 | MRPL35 | mitochondrial ribosomal protein L35 | 2 | 2 | ||||||||
MIRT566850 | LRRC58 | leucine rich repeat containing 58 | 2 | 2 | ||||||||
MIRT568077 | CELF2 | CUGBP Elav-like family member 2 | 2 | 2 | ||||||||
MIRT576826 | Tgfbr3 | transforming growth factor, beta receptor III | 2 | 2 | ||||||||
MIRT608870 | NR2E1 | nuclear receptor subfamily 2 group E member 1 | 2 | 4 | ||||||||
MIRT611997 | VAC14 | Vac14, PIKFYVE complex component | 2 | 2 | ||||||||
MIRT614054 | FAM89A | family with sequence similarity 89 member A | 2 | 2 | ||||||||
MIRT618800 | SPATA21 | spermatogenesis associated 21 | 2 | 2 | ||||||||
MIRT619389 | RSPH3 | radial spoke head 3 homolog | 2 | 2 | ||||||||
MIRT622282 | SH3TC2 | SH3 domain and tetratricopeptide repeats 2 | 2 | 2 | ||||||||
MIRT624026 | EN2 | engrailed homeobox 2 | 2 | 2 | ||||||||
MIRT626000 | MPEG1 | macrophage expressed 1 | 2 | 2 | ||||||||
MIRT641792 | USP32 | ubiquitin specific peptidase 32 | 2 | 2 | ||||||||
MIRT651599 | WDFY2 | WD repeat and FYVE domain containing 2 | 2 | 2 | ||||||||
MIRT659662 | CDC73 | cell division cycle 73 | 2 | 2 | ||||||||
MIRT663010 | KIAA1586 | KIAA1586 | 2 | 2 | ||||||||
MIRT663561 | ASTN2 | astrotactin 2 | 2 | 2 | ||||||||
MIRT669312 | C16orf72 | chromosome 16 open reading frame 72 | 2 | 2 | ||||||||
MIRT685216 | POTED | POTE ankyrin domain family member D | 2 | 2 | ||||||||
MIRT695757 | ZNF117 | zinc finger protein 117 | 2 | 2 | ||||||||
MIRT697909 | TXNRD1 | thioredoxin reductase 1 | 2 | 2 | ||||||||
MIRT707181 | RPH3A | rabphilin 3A | 2 | 2 | ||||||||
MIRT707214 | TRIM13 | tripartite motif containing 13 | 2 | 2 | ||||||||
MIRT707478 | SLCO4C1 | solute carrier organic anion transporter family member 4C1 | 2 | 2 | ||||||||
MIRT719507 | LMAN2L | lectin, mannose binding 2 like | 2 | 2 | ||||||||
MIRT755814 | PARP1 | poly(ADP-ribose) polymerase 1 | 2 | 1 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|